newsfilter
← Latest News
GlobeNewswire·

89bio to Participate in the BofA Securities 2024 Health Care Conference

SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver